Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Items 401–500 of 661
Tissue-based in vitro and ex vivo models for nasal permeability studies
Sosnik, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100094-6.00014-6 · Cited by 12
Shah, M. R., Imran, M. A., & Ullah, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52729-3.00004-4 · Cited by 10
Kumar, A., & Jain, S. K. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2016.1160405 · Cited by 11
Ryan, R. C., Leslie, M. N., He, P., Young, P. M., Hoyos, C. M., Ong, H. X., & Traini, D. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115575 · Cited by 11
Optimal Dose of Intranasal Midazolam for Procedural Sedation in Children
Tsze, D. S., Woodward, H. A., McLaren, S. H., Leu, C., Venn, A. M. R., Hu, N. Y., Flores‐Sanchez, P. L., Stefan, B. R., Shen, S. T., Ekladios, M., et al. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.2181 · Cited by 9
Nose-to-brain delivery of biologics and stem cells
Agrawal, M., Konwar, A. N., Alexander, A., & Borse, V. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00015-1 · Cited by 9
Translational Considerations in the Development of Intranasal Treatments for Epilepsy
Prentice, R. N., & Rizwan, S. B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010233 · Cited by 11
Ozeer, F. Z., Nagandran, S., Wu, Y. S., Wong, L. S., Stephen, A., Lee, M. F., Kijsomporn, J., Guad, R. M., Batumalaie, K., Oyewusi, H. A., et al. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-05845-x · Cited by 12
Salamah, M., Volk, B., Lekli, I., Bak, I., Gyöngyösi, A., Kozma, G., Kónya, Z., Szalenkó-Tőkés, Á., Kiricsi, Á., Rovó, L., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s518486 · Cited by 9
Nasal Inserts for Drug Delivery: An Overview
Alğin, E. (2014) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v13i3.22 · Cited by 10
Olfaction, among the First Senses to Develop and Decline
Brai, E., & Alberi, L. A. (2018) · InTech eBooks · doi:10.5772/intechopen.75061 · Cited by 16
Nanotechnology-based Strategies As Novel Therapies in Gliomas
Gaikwad, P. S., & Banerjee, R. (2018) · Therapeutic Delivery · doi:10.4155/tde-2018-0022 · Cited by 9
Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery.
Maher, M. A., Kandeel, W. A., Hammam, O. A., Attia, Y. M., Mahmoud, S. S., & Salah, M. (2022) · PubMed · doi:10.14670/hh-18-421 · Cited by 10
Emerging Trends and Future Challenges of Nanovaccine Delivery via Nasal Route
Dewangan, H. K., Raghuvanshi, A., & Shah, K. (2022) · Current Drug Targets · doi:10.2174/1389450124666221205162256 · Cited by 10
Barends, C. R. M., den Daas, I., Driesens, M. K., Visser, A., Absalom, A. R., & Colin, P. J. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.04.035 · Cited by 9
Cell Culture Models for Drug Transport Studies
Kalashnikova, I. V., Albekairi, N. A., Ali, S., Al-Enazy, S., & Rytting, E. (2016) · Drug Delivery · doi:10.1002/9781118833322.ch7 · Cited by 10
A Review on Nose-to-Brain Drug Delivery
Kamble, M. S., Bhalerao, K. K., Bhosale, A., Chaudhari, P., Govind, S., & Sable, R. (2013) · Cited by 9
Functionalized Polymeric Nanostructures for Mucosal Drug Delivery
Thwala, L. N., Santander-Ortega, M. J., Lozano, M. V., & Csaba, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00015-x · Cited by 11
Yusuf, M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102534 · Cited by 9
Novel Delivery Systems for Anti-Allergic Agents: Allergic Disease and Innovative Treatments
Lopes, C. M., Barata, P., & Oliveira, R. (2015) · Current Drug Delivery · doi:10.2174/1567201812666150421111222 · Cited by 9
Formulation development and characterization of oxcarbazepine microemulsion for intranasal delivery
Tirunagari, M., Sameen, J., & Nandagopal, A. (2017) · ACTA Pharmaceutica Sciencia · doi:10.23893/1307-2080.aps.05513 · Cited by 9
Mucus as Physiological Barrier to Intracellular Delivery
Fröhlich, E., & Roblegg, E. (2014) · Fundamental biomedical technologies · doi:10.1007/978-94-017-8896-0_7 · Cited by 9
Inoue, D., Seto, Y., & To, H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070863 · Cited by 8
The Safety of High-Dose Intranasal Fentanyl in the Pediatric Emergency Department
Anderson, T., Harrell, C., Snider, M., & Kink, R. (2022) · Pediatric Emergency Care · doi:10.1097/pec.0000000000002627 · Cited by 8
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays
Patterlini, V., Guareschi, F., D’Angelo, D., Baldini, S., Meto, S., Kamal, D. M., Fabrizzi, P., Buttini, F., Mösges, R., & Sonvico, F. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16080989 · Cited by 8
Sayyed, M. E., & Hatem, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106173 · Cited by 9
Hasannejad, F., Arab, S., Farahmand, L., Darvishi, B., & Bahraminasab, M. (2025) · Iranian Polymer Journal · doi:10.1007/s13726-024-01427-1 · Cited by 8
Seifelnasr, A., Zare, F., Si, X. A., & Xi, J. (2025) · Liquids · doi:10.3390/liquids5020011 · Cited by 8
Non-Aqueous Nanoemulsions: An Innovative Lipid-Based Drug Carrier
Virmani, T., Kumar, G., & Pathak, K. (2022) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-7998-8908-3.ch006 · Cited by 12
Chen, C., & Gupta, A. (2014) · Pain Management · doi:10.2217/pmt.14.32 · Cited by 8
Efficacy and Safety of Nasal Administration of “Na-no-L-DOPA” Based on PLGA Nanoparticles
Кондрашева, И. Г., Антипова, Т. А., Barsegyan, G. G., Gambaryan, P. Y., Guseva, A. A., & Kamensky, A. A. (2012) · Engineering · doi:10.4236/eng.2012.410b007 · Cited by 8
Young, J. R., Sawe, H. R., Mfinanga, J. A., Nshom, E., Helm, E., Moore, C. G., Runyon, M. S., & Reynolds, S. L. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017190 · Cited by 8
Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery
Lalan, M. S., Tandel, H., Lalani, R., Patel, V., & Misra, A. R. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_9 · Cited by 14
Haghjoo, E., Sadeghniiat‐Haghighi, K., Hashem-Dabaghian, F., Shojaii, A., & Kenari, H. M. (2019) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres19.654_7.6.471 · Cited by 8
Lipid nanocapsules: A Novel Strategy for Brain Targeting via Nasal Administration
Ibrahim, M. M., Basalious, E. B., Nabarawi, M. E., & Makhlouf, A. I. A. (2024) · Journal of Research in Pharmacy · doi:10.29228/jrp.717 · Cited by 9
Engineering chitosan-functionalized liposomes for targeted drug delivery and biomedical applications
Ren, Z., Gao, W., Li, X., Jing, Y., Gu, M., Xing, P., Jing, Z., Ashrafizadeh, M., Ren, J., Orive, G., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150563 · Cited by 8
Arbabian, A., Driscoll, T. P., Li, Y., & Grant, S. C. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.02.049 · Cited by 8
Ketorolac as an Analgesic in Pediatric Acute Pain Management: A Systematic Review and Meta-analysis
Alsabri, M., Diab, R. A., Alqeeq, B. F., Rifai, M. K., Abouelmagd, K., Abo‐elnour, D. E., & Gamboa, L. L. (2025) · Pediatric Emergency Care · doi:10.1097/pec.0000000000003381 · Cited by 7
Maniyar, A. J., Patel, G. M., Shelat, P., & Lalwani, A. (2016) · Journal of Young Pharmacists · doi:10.5530/jyp.2016.4.12 · Cited by 7
Nano-vaccination Strategies: Applications and Challenges for Intranasal Immunization
Pandya, T., Joshi, P., Pathak, R., & Shah, S. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220727105901 · Cited by 8
Polysaccharide-based platforms for nasal delivery: design, features, and perspectives
Elmowafy, E. M., & Soliman, M. E. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00626-x · Cited by 8
Maisto, N., & Mango, D. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101057 · Cited by 7
Ahmad, N., Ahmad, R., Alam, A., Ahmad, F. J., & Rub, R. A. (2018) · Current Pharmaceutical Analysis · doi:10.2174/1573412914666180530073613 · Cited by 9
From the nose to the brain, nanomedicine drug delivery
Zeeshan, F., Mishra, D. K., & Kesharwani, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820466-5.00008-9 · Cited by 8
Laddha, U. D., & Tagalpallewar, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00002-3 · Cited by 9
Xu, J., Li, S., Wang, X., Liu, J., Shan, P., Zhou, Y., Zhao, J., Wang, Z., Xu, C., Chen, M., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0133-y · Cited by 7
A Review: Nose to Brain Drug Delivery for Various CNS Disorders
Jadhav, S., Sahoo, S., & Mishra, S. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-16848-3_35 · Cited by 7
Seidkhani, E., Moradi, F., Rustamzadeh, A., Simorgh, S., Shirvalilou, S., Mehdizadeh, M., Dehghani, H., Akbarnejad, Z., Motevalian, M., & Gorgich, E. A. C. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116754 · Cited by 7
Wani, S. N., Singh, S., Sharma, N., Zahoor, I., Grewal, S., & Gupta, S. (2023) · BioNanoScience · doi:10.1007/s12668-023-01249-0 · Cited by 8
Wang, H., Huang, J., Yang, S., Zhang, X.-F., Yang, X., Cui, C., Zou, C., Li, L., Zhang, M., Mao, M.-F., et al. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00329-9 · Cited by 7
Evaluation of the usefulness of hydroxypropyl cellulose and sucrose in the nasal influenza vaccine
Mieda, S., Inoue, K., Ito, A., Yada, S., Miyajima, M., & Fukami, T. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103165 · Cited by 6
Kesavan, J. S., Kuypers, K., Sommerville, D. R., Sedberry, K., & Laube, B. L. (2023) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2022.0056 · Cited by 6
Wan, G., Li, Z., Gu, L., Sun, Y., Wang, Y., Wang, Y., Geng, R., Chen, Y., Ma, W., Bao, X., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101652 · Cited by 6
Shevchenko, K. V., Dulov, S. A., Андреева, Л. А., Nagaev, I. Y., Shevchenko, V. P., Radilov, A. S., & Myasoedov, N. F. (2016) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162016020126 · Cited by 6
Advances in Neurotherapeutic Delivery Technologies
Pradeep, K. (2015) · OMICS International eBooks · doi:10.4172/978-1-63278-036-2-037 · Cited by 7
Nicholas, T. G., & Husbands, E. (2022) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2022.2028955 · Cited by 6
Novel Long-Acting Oxytocin Analog with Increased Efficacy in Reducing Food Intake and Body Weight
Elfers, C., Blevins, J. E., Salameh, T. S., Lawson, E. A., Silva, D., Kiselyov, A. S., & Roth, C. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911249 · Cited by 6
Routes of administration of insulin
Sonia, T. A., & Sharma, C. P. (2014) · Elsevier eBooks · doi:10.1533/9781908818683.59 · Cited by 7
The Use of Intranasal Midazolam in a Special Care Dentistry Department: Technique and Cases
Drysdale, D. (2015) · Primary Dental Journal · doi:10.1177/205016841500400215 · Cited by 6
Bregstein, J. S., Wagh, A. M., & Tsze, D. S. (2019) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2019.05.020 · Cited by 7
Prehospital Analgesia and Sedation: a Perspective from the Battlefield
Fisher, A. D., DesRosiers, T., & Drew, B. G. (2020) · Current Trauma Reports · doi:10.1007/s40719-020-00199-2 · Cited by 5
Walenga, R. L., Babiskin, A. H., Boyce, H. J., Feng, X. L., Zidan, A. S., Kamal, N. S., Xu, X., Kim, M., & Zhao, L. Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.049 · Cited by 5
Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model
Al-Sheakly, B. K. S., Sharif‐Askari, F. S., Sharif‐Askari, N. S., Zakri, A. M., Mdkhana, B., Eladham, M. W., Hundt, J. E., Hachim, I. Y., & Halwani, R. (2025) · Inflammation Research · doi:10.1007/s00011-024-01991-5 · Cited by 6
Alam, S., Hafeez, A., Ansari, J. A., Kaushal, V., & Kushwaha, S. P. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06367-2 · Cited by 7
Wei, Y., Ai, H. O. R. I., Chen, I.-Y., TAMOGI, H., Hirokawa, T., Kato, K., ITAMI, T., Sano, T., & YAMASHITA, K. (2022) · Journal of Veterinary Medical Science · doi:10.1292/jvms.21-0648 · Cited by 5
Intranasal nanocrystals of tadalafil: in vitro characterisation and in vivo pharmacokinetic study
Darweesh, R. S., Alshriem, L. A., & Al‐Nemrawi, N. K. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e120458 · Cited by 5
Drug Delivery Across the Blood–Brain Barrier with Focused Ultrasound and Microbubbles
Meairs, S. P. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_37 · Cited by 7
Drug Delivery Across the Nasal Mucosa
Armstrong, M., Walker, S., Mains, J., & WILSON, C. G. (2014) · Wiley eBooks · doi:10.1002/9781118794203.ch03 · Cited by 6
Lee, J.-J., Shim, A., Jeong, J. Y., Lee, S. Y., Ko, H., & Cho, H. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.050 · Cited by 5
Yanmaz, L. E. (2017) · Atatürk Üniversitesi Veteriner Bilimleri Dergisi · doi:10.17094/ataunivbd.347957 · Cited by 5
The pharmacokinetics of intranasal droperidol in volunteers characterised via population modelling
Cooper, I., Landersdorfer, C. B., John, A. G. S., & Graudins, A. (2018) · SAGE Open Medicine · doi:10.1177/2050312118813283 · Cited by 5
A Novel Calcium Channel Blocker: Etripamil
Weintraub, S. F., & Frishman, W. H. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000362 · Cited by 5
Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)
Wang, D., Du, Y. L., Zhang, W., Han, X., Zhang, H., Wang, Z., Liu, N., Li, M., Gao, X., Zhuang, X., et al. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1889718 · Cited by 5
Intranasal route: The green corridor for Alzheimer's disease therapeutics
Chaudhury, S. S., Sinha, K., & Mukhopadhyay, C. D. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102791 · Cited by 5
The nasal route, advanced drug delivery systems and evaluation: a review
Rutvik, K., Meshva, P., Patel, D. V., & Dholakia, M. S. (2023) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_122_22 · Cited by 5
A REVIEW ON APPLICATION OF NATURAL BIOADHESIVE POLYSACCHARIDES FOR INTRANASAL DRUG DELIVERY
Minde, D. S., Singh, A. K., & Saudagar, R. B. (2015) · Cited by 5
Drug transporters in the nasal epithelia and their contribution in drug delivery
Al-Ghabeish, M., Donovan, M., Flanagan, D. R., Salem, A. K., Assem, M., & Scheetz, T. E. (2014) · doi:10.17077/etd.9mkkvyzi · Cited by 8
The measurement of fluid energy loss during flow.
Siroky, M. B., Willischer, M. K., & Krane, R. J. (1980) · PubMed · Cited by 5
Molecular Docking Studies of Aromatherapy Oils Against SARS-COV-2Preprint
Jesus, M. D., Gaza, J. T., Junio, H. A., & Nellas, R. B. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12867308.v1 · Cited by 5
Pharmacokinetics of intranasal drugs, still a missed opportunity?
Sardu, M. L., & Poggesi, I. (2024) · Xenobiotica · doi:10.1080/00498254.2024.2349046 · Cited by 4
Advances in polysaccharide-based formulations for intranasal drug delivery: A review
Abubakar, B. D., Rosdan, B. S. M., Mohtar, N., & Nurul, A. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106266 · Cited by 7
Fong, T. Y. A., Thirugnanasampanthar, M., Iley, T., Parry, M., & Forbes, B. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126991 · Cited by 4
Gouveia, F., Carona, A., Lacerda, M., Bicker, J., Camins, A., Cruz, M. T., Ettcheto, M., Falcão, A. C., & Fortuna, A. C. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116616 · Cited by 5
Self-citationIntranasal Drug Delivery of Antiviral Agents - A Revisit and Way Forward
Jino Affrald, R., & Narayan, S. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230727100812 · Cited by 4
Nose to brain drug delivery through advanced drug delivery systems
Kumar, R., Singh, A., Kapoor, B., Hussain, M. S., Singh, S. K., Dua, K., Dureja, H., Thomas, N. V., & Gulati, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00001-9 · Cited by 7
Khan, M. F., Ahmad, N., Ansari, K. A., Ullah, Z., Ibrahim, H. O., Alyami, H. M., Alqahtani, A. J., & Ahmad, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c00783 · Cited by 5
Wegner, G. R. M., Wegner, B. F. M., Cumming, H., de Oliveira, H. G., Campos, L. R., da Silva, L. H. D., Ferreira, C. H. O., Miranda, A. M., Donato, A. B., & do Nascimento, T. S. (2025) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2025.111903 · Cited by 4
Intranasal Delivery of Therapeutic Peptides for Treatment of Ischemic Brain Injury
Huang, T., Smith, A., Chen, J., & Li, P. (2019) · Springer series in translational stroke research · doi:10.1007/978-3-030-16715-8_6 · Cited by 4
Dretchen, K. L., Mesa, Z., Robben, M., Slade, D., Hill, S., Forsee, K. M., Croutch, C. R., & Mesa, M. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02829-5 · Cited by 5
Hilario, G., Sulczewski, F. B., Liszbinski, R. B., Mello, L. D., Hagen, G., Fazolo, T., Neto, J. D. C. F., Dallegrave, E., Romão, P. R. T., Aguirre, T. A. S., et al. (2021) · IET Nanobiotechnology · doi:10.1049/nbt2.12043 · Cited by 4
Raofi, S., Kinjo, M., Sun, D. D., Li, Z. F., Boyce, H. J., Natarajan, K., Frost, M. M., Zhao, L. Y., Luke, M. C., Lionberger, R. A., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.13053 · Cited by 4
Biodistribution analysis of an intranasal-delivered peptide by the nanoSPECT/CT imaging
Lo, W.-L., Wang, Y., Chen, H., Wang, S., Chen, L., & Chen, R. P. ‐. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103454 · Cited by 4
Nanovesicles for nasal drug delivery
Paudwal, G., Banjare, N., & Gupta, P. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00024-9 · Cited by 7
Pharmaceutical Considerations of Nasal In-Situ Gel As A Drug Delivery System
Khatri, U., Saini, S., & Bharkatiya, M. (2021) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v9i3.950 · Cited by 4
Nose-to-Brain Delivery of Peptides and Proteins
Durgun, M. E., Çamlık, G., Değim, İ. T., & Özsoy, Y. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_10 · Cited by 6
Intranasal insulin – effects on the sense of smell
Sienkiewicz-Oleszkiewicz, B., Oleszkiewicz, A., Bock, M. A., & Hummel, T. R. (2023) · Rhinology Journal · doi:10.4193/rhin23.036 · Cited by 4
What is the Evidence for Using Intranasal Medicine in the Prehospital Setting? A Systematic Review
Bowman, A., Domke, C., & Morton, S. (2024) · Prehospital Emergency Care · doi:10.1080/10903127.2024.2357598 · Cited by 3
Comparison of short nozzle and long nozzle spray in sinonasal drug delivery: a cadaveric study
Kapadia, M., Grullo, P. E. R., & Tarabichi, M. (2019) · Ear Nose & Throat Journal · doi:10.1177/0145561319846830 · Cited by 4
Molecular Docking Studies of Aromatherapy Oils Against SARS-COV-2Preprint
Jesus, M. D., Gaza, J. T., Junio, H. A., & Nellas, R. B. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12867308 · Cited by 4
Bozza, A., Bordano, V., Marengo, A., Muntoni, E., Marini, E., Lazzarato, L., Dianzani, C., Monge, C., Rosa, A. C., Cangemi, L., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081051 · Cited by 3
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.